"Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)"

Endocrine. 2021 Dec;74(3):632-637. doi: 10.1007/s12020-021-02805-y. Epub 2021 Jun 28.

Abstract

Purpose: To report the incidence of 4-12% of differentiated thyroid cancer (DTC) and up to 50% of benign thyroid nodular disease and to describe nodular thyroid disease in a multicentre pediatric population with PTEN mutations.

Methods: Retrospective data of pediatric patients with PTEN mutations collected from tertiary Departments of Pediatric Endocrinology of Turin, Milan and Genua, Italy, in the period 2010-2020.

Results: Seventeen children with PTEN mutations were recruited in the study. Thyroid involvement was present in 12/17 (70.6%) subjects, showing a multinodular struma in 6/17 (35.3%), nodules with benign ultrasound features in 5/17 (29.4%) and a follicular adenoma in 1/17 (6%). No correlation was found between thyroid disease and gender, puberty, vascular manifestations, delayed development, or brain MRI abnormalities, while multiple lipomas were associated with thyroid disease (p = 0.03), as was macrocephaly. Standard Deviation (SD) score head circumference was 4.35 ± 1.35 cm in subjects with thyroid disease, 3 ± 0.43 cm (p = 0.02) in the group without thyroid disease. Thyroid involvement was present in all subjects with mutations in exon 6 (4/4) and exon 8 (3/3) of the PTEN gene (p = 0.02).

Conclusion: In the presented cohort, benign thyroid disorders were prevalent, with no evidence of DTC. A correlation was found between thyroid lesions and head circumference and the occurrence of multiple lipomas. Future studies in larger cohorts should assess whether risk stratification is needed when recommending surveillance strategies in children or young adolescents with PTEN hamartoma syndrome.

Keywords: Differentiated thyroid cancer; PTEN mutation; Pediatric age; Thyroid nodule.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Child
  • Hamartoma Syndrome, Multiple* / diagnostic imaging
  • Hamartoma Syndrome, Multiple* / genetics
  • Humans
  • Mutation
  • PTEN Phosphohydrolase / genetics
  • Retrospective Studies
  • Thyroid Diseases*

Substances

  • PTEN Phosphohydrolase
  • PTEN protein, human